ENDRA Life Sciences Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update

Go back to ENDRA Life Sciences Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update

ENDRA Life Sciences (NDRA) Tops Q4 EPS by 1c

March 30, 2022 4:09 PM EDT

ENDRA Life Sciences (NASDAQ: NDRA) reported Q4 EPS of ($0.07), $0.01 better than the analyst estimate of ($0.08).

Cash and cash equivalents were $9.5 million as of December 31, 2021.

For earnings history and earnings-related data on ENDRA Life Sciences (NDRA) click here.

... More